Science

Research and Development

At Jazz, we use patient-centric innovation to drive our research and development (R&D) strategy, investment and growth. This starts with identifying unmet needs across rare disease including rare epilepsies, cancers and sleep disorders—and take the best discovery and development approach to solutions, whether that leverages our proprietary, industry-defining research or our collaborations with leading investigators and bioscience companies.

We believe all people, including those who live with rare disease, deserve new and better therapeutic options. Our teams are committed to innovation and use their expertise to lead clinical programs across rare epilepsies, cancers and sleep disorders. As part of our commitment to patients with unmet needs, we continually work to expand the science behind our therapies, acquire rights to develop new medicines, and partner with researchers, academia and other industry leaders to advance molecules with great potential to create new or better standards of care.